Connect with us

Technology

British Technology company, C the Signs, selected by the White House-Backed Accelerator Programme, CancerX, to half Cancer Deaths

Published

on

LONDON, Feb. 27, 2024 /PRNewswire/ — C the Signs, a British AI technology company founded by NHS Doctors at the forefront of early cancer detection, has been announced as part of the inaugural cohort of the White House CancerX Accelerator programme.

CancerX was unveiled by the White House in a landmark announcement last year to spearhead innovation in oncology. The initiative aims to achieve the ambitious ‘Cancer Moonshot’ goals set by the administration: to reduce cancer mortality by at least 50% over the next 25 years, and to enhance the quality of life for individuals and families living with and surviving cancer. The CancerX Accelerator programme aims to promote and fortify digital innovations in oncology by providing promising startups an opportunity to collaborate with leading cancer organizations.

C the Signs is an AI cancer prediction platform that identifies patients at risk of cancer at the earliest and most curable stage of the disease. It has so far detected over 25,000 patients with cancer through its innovative AI approach, with a 98% accuracy in ruling in or out cancer risk.  It was selected as one of 16 companies – and the only British company – to be part of the first CancerX Accelerator, C the Signs was selected as it represents one of the most progressive and effective ways of driving digital innovation in oncology.

Dr. Bea Bakshi, CEO & Co-Founder of C the Signs, says:

“As a doctor, I am deeply moved and profoundly grateful for our selection to participate in the inaugural CancerX accelerator. Launched by the White House, this initiative marks a significant step toward realizing the Cancer Moonshot’s vision of a 50% reduction in cancer mortality. At C the Signs, our mission is firmly rooted in the belief that early detection can change the course of this disease, aiming for a future where surviving cancer is the norm rather than the exception. The success we’ve achieved within the UK’s National Health Service so far fills me with immense pride and hope. As we embark on this journey in the United States, I am incredibly enthusiastic about collaborating with the brightest minds in oncology and industry pioneers; what we can collectively achieve is boundless. This is more than just an opportunity; it’s a pivotal moment to lead with heart and affect meaningful change.”

Aphrodite Spanou, Director of Healthcare UK, Department of Health and Social Care, NHS England and the Department for Business and Trade, says:

“We are delighted for C the Signs for being selected as one of the inaugural companies, by the White House’s CancerX Accelerator. This recognition is a testament to the UK’s leadership in healthcare innovation and our capacity to create technology solutions with a global impact. C the Signs’ work in early cancer detection not only exemplifies British ingenuity but also aligns perfectly with our objectives of showcasing how local innovations can have international reach and significance.”

C the Signs was selected from hundreds of applicants after an intensive evaluation process involving three rounds of judging and will now have the unprecedented opportunity to collaborate with the CancerX Champions from leading cancer and technology innovators including AstraZeneca, Intel, Dell Technologies, AWS, Debiopharm Innovation Fund, Mass Challenge, Reveal HealthTech, Atrium Health, Oncology Ventures, and UC Davis Health.

NOTES FOR EDITORS:

ABOUT CANCERX:
Part of the U.S. Cancer Moonshot initiative, CancerX is a public-private partnership announced by The White House as a national accelerator to boost innovation in the fight against cancer. Co-hosted by the Digital Medicine Society (DiMe) and Moffitt Cancer Center, alongside the Office of the National Coordinator for Health Information Technology (ONC) and Office of the Assistant Secretary for Health (OASH), it convenes the many diverse stakeholders needed to unleash the power of innovation to create a future that’s free of cancer burden. To learn more or participate in CancerX’s pre-competitive, evidence-generating efforts; Accelerator cohort; or demonstration projects, visit www.cancerx.health

ABOUT THE CANCERX ACCELERATOR:
The CancerX Accelerator program aims to promote and fortify digital innovations in oncology by providing promising startups an opportunity to collaborate with leading cancer organizations. Startup participants benefit from valuable mentorship, comprehensive training and direct access to key players in the health care industry, including providers, payers and pharmaceutical companies. This collaborative environment enables startups to develop, test and implement their cancer focused innovation on a larger scale.
https://cancerx.health/accelerator/

ABOUT THE 16 START-UPS:
A team of Accelerator Champions and judges from the CancerX community led three rounds of judging earlier this year to select this impressive cohort group. The full list of startups includes: The Blue Box, C the Signs, Cancer Insights, Curvia, EnteroTrack, Gesund.ai, Gray Oncology, LindAI, Mika Health, Navya, Oatmeal Health, Orbit Genomics, Realyze Intelligence, Reimagine Care, SurvivorPlan, and Xanthos.

ABOUT THE PROGRAMME:

As a member of the CancerX accelerator, start-ups will now participate in a rich, 4-month program where they will:

Engage with members of the healthcare ecosystem to test and validate their solutions.Get expert guidance from CancerX Mentors.Graduate with a roadmap to successfully scale our company, an opportunity to move forward with our sponsor, and a community that will continue to support our development.

FURTHER INFORMATION:

–  For further information on The White House Cancer Moonshot Announcement
https://www.whitehouse.gov/briefing-room/statements-releases/2022/02/02/fact-sheet-president-biden-reignites-cancer-moonshot-to-end-cancer-as-we-know-it/#:~:text=Based%20on%20the%20progress%20made%20and%20the%20possibility,and%20their%20families%20living%20with%20and%20surviving%20cancer.
–  For further questions or queries on CancerX: laura@dimesociety.org
–  For the CancerX logo (Horizontal + Vertical)
–  For further information on C the Signs: www.cthesigns.com
–  For further information for press or media queries please contact: Charlotte Beams, Communications Officer, charlottebeames@cthesigns.net

ABOUT HEALTHCARE UK:

Healthcare UK is a joint initiative of the Department of Health and Social Care, NHS England and the Department for Business and Trade. Healthcare UK promotes the British healthcare sector internationally to drive export opportunities and works with the NHS to strengthen its capacity to operate and succeed internationally.

View original content:https://www.prnewswire.com/news-releases/british-technology-company-c-the-signs-selected-by-the-white-house-backed-accelerator-programme-cancerx-to-half-cancer-deaths-302071760.html

SOURCE C the Signs

Continue Reading

Technology

Datavault AI expands deployment, strengthens market position on Available neocloud infrastructure

Published

on

By

Datavault’s deployment onto SanQtum is expanding: in addition to NYC and Philadelphia, the company is also live with edge AI on a third hub in Washington, DC, and will be live in three more cities by the end of the year.

TYSONS CORNER, Va. and PHILADELPHIA, Sept. 8, 2026 /PRNewswire-PRWeb/ — In a pair of announcements in early January 2026, Datavault AI announced nationwide deployment of the company’s DataValue, DataScore, and Information Data Exchange (IDE) solutions onto Available’s SanQtum neocloud platform, along with initial edge AI hubs in New York City and Philadelphia in collaboration with Available and IBM.

Eight months later, Datavault’s deployment onto SanQtum is expanding: in addition to NYC and Philadelphia, the company is also live with edge AI on a third hub in Washington, DC, and will be live in three more cities — San Francisco, Chicago, and Raleigh (NC) — totaling six by the end of the year.

Complementing these “super node” hubs, ~200 Available Infrastructure micro edge sites located at cell towers across 30 US cities are operating or under construction, with edge clusters in 70 cities to be added to Available’s neocloud in the coming months. This represents phase 1 of Available’s US neocloud infrastructure buildout, which the company unveiled as Project Qestrel in March.

Market forecasts show very strong demand for neocloud offerings. Synergy Research Group reports $9B (US) in Q4 2025, up 223% year-over-year, exceeding $25B (US) total in 2025 and a 58% CAGR approaching $400B by 2031. The World Economic Forum projects the neocloud market at $250B by 2030.

Companies that can differentiate within this neocloud market segment — such as with sovereign architecture, ultra-low-latency for real-time AI inference, and superior cybersecurity — are well-positioned to excel. The entire SanQtum platform is purpose-built to such specs: sovereign, resilient, edge-first, zero trust, and Q Day ready. These are all attributes that in turn strengthen Datavault’s value proposition for its customers.

The next step in Datavault’s deployment onto the Project Qestrel fleet of Available’s SanQtum neocloud is manufacturing $QEST coins to monetize the value of the associated compute, including moving into compelling new markets such as sovereign edge AI inference. Available is proud to provide the foundation for Datavault CEO Nate Bradley and his team to embark on a game-changing endeavor with their solutions around digital twins, tokenization of real-world assets (RWA), and more.

About Available Infrastructure

Based in Northern Virginia along the Washington, DC, beltway, Available Infrastructure offers SanQtum: a secure, sovereign environment for running mission critical applications, deploying AI inference, and storing sensitive data. SanQtum is offered as an integrated, managed service that conveniently bundles three crucial components: a cybersecure zero trust network overlay, high-performance neocloud compute at urban and frontier micro edge sites, and AI inference governance and orchestration. Available Infrastructure is an IBM Platinum Partner.

For more information, visit www.availableinfrastructure.com.

About DataVault AI

About Datavault AI Datavault AI Inc. (Nasdaq: DVLT) is an Artificial Intelligence Platform (“AIP”) company focused on transforming data and real-world assets into intelligent, secure and monetizable digital assets. The Company’s integrated platform combines artificial intelligence, an AI-driven inference layer, data valuation, tokenization, cybersecurity, high-performance computing and exchange technologies to support the lifecycle of data and digital assets—from identification and valuation through tokenization, commercialization and monetization.

Datavault AI operates through two synergistic divisions: Data Science and Acoustic Science. The Data Science division includes the Company’s patented Data Vault®, DataValue®, and DataScore® technologies, together with its cybersecurity, tokenization and exchange capabilities. The Acoustic Science division includes WiSA®, ADIO® and related spatial audio and data-over-sound technologies, as well as the Company’s events and experiential media businesses, including CompuSystems, Inc., operated under the Event Citadel brand, and API Media Innovations Inc.

Together, these capabilities form an integrated AI platform designed to connect data, intelligence, value and markets, enabling enterprises, institutions and asset owners to identify, protect, value and monetize data and real-world assets.

The Company is headquartered in Philadelphia, PA. For more information, visit www.dvlt.ai. Investor information is available at ir.datavaultsite.com. Technology news and insights are published at dvlt.ai/insights.

Media Contact

Inflection Point Agency, Available Infrastructure, 1 (719) 357-8344, nikki@inflectionpointagency.com, https://availableinfrastructure.com/

View original content:https://www.prweb.com/releases/datavault-ai-expands-deployment-strengthens-market-position-on-available-neocloud-infrastructure-302872536.html

SOURCE Available Infrastructure

Continue Reading

Technology

Harbor Compliance Accelerates Growth Strategy, Earns 8th Inc. 5000 Recognition

Published

on

By

New CEO, Strengthened Board, and Growth Investment from Bregal Sagemount Fuel the Company’s Next Phase of Expansion

LANCASTER, Pa., Sept. 8, 2026 /PRNewswire/ — Harbor Compliance, a leading provider of compliance, licensing, and registered agent services, is executing an ambitious growth strategy backed by new leadership, a strengthened board, and a committed capital partner. That momentum is reflected in the company’s eighth appearance on the Inc. 5000 list of America’s fastest-growing private companies, with three-year revenue growth of 55 percent.

In February 2026, Harbor Compliance secured a majority growth investment from Bregal Sagemount, a growth-focused private capital firm, and appointed Chad Nuss as Chief Executive Officer. Industry veteran John Weber, former CEO of CT Corporation, joined the company’s board of directors alongside partners from Bregal Sagemount, bringing decades of regulatory and compliance leadership to guide the company’s next phase. The investment is fueling continued expansion of Harbor Compliance’s regulatory data, software, and managed services — the same combination that has driven the company’s growth since it was founded in 2012 and that today serves more than 40,000 customers nationwide.

“This recognition reflects the alignment we have across our leadership team, board, and investors around a single strategy: making compliance simple for the customers we serve,” said Chad Nuss, CEO of Harbor Compliance. “Sustaining growth over eight years means making our customers’ lives easier no matter how fast requirements change. That’s why we listen to the needs in the market, continue to expand our compliance services, and deliver additional capabilities through technology. Organizations can see and address their full compliance picture in one place rather than piecing it together state by state. This complete regulatory compliance is the peace of mind organizations are asking for.”

“Harbor Compliance has the rare combination of a differentiated product, a large and growing market, and a leadership team that knows how to execute,” said John Weber, board member and former CEO of CT Corporation. “That combination is why the board and our investment partners are confident in the company’s path forward.”

Through a unique combination of proprietary data, advanced software, and expert support, Harbor Compliance helps businesses and nonprofits manage the registration rules, licensing categories, renewal calendars, and reporting obligations that vary by jurisdiction and change with little warning. From a single interface, users can track renewal dates, assign tasks to colleagues, store records, and access registered agent documents. The software is available as a service and also serves as the foundation of the company’s managed services.

About Harbor Compliance

Harbor Compliance helps organizations simplify regulatory compliance. Through Harbor Everywhere, Harbor Compliance delivers its purpose-built entity, licensing, tax registration, and registered agent data directly inside the operational systems organizations already use to run their business. Trusted by more than 40,000 organizations nationwide, Harbor Compliance combines purpose-built technology with expert support to help organizations stay compliant and confidently grow across jurisdictions.

Media Contact:
Brock Klinger, Director of Sales & Marketing
717.431.9022
bklinger@harborcompliance.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/harbor-compliance-accelerates-growth-strategy-earns-8th-inc-5000-recognition-302872599.html

SOURCE Harbor Compliance

Continue Reading

Technology

Panasonic Automotive Systems Group secures SBTi validation for greenhouse gas emissions reduction targets

Published

on

By

YOKOHAMA, Japan, Sept. 8, 2026 /PRNewswire/ — Panasonic Automotive Systems Co., Ltd. (Headquarters: Yokohama, Kanagawa, Japan; President: Masashi Nagayasu) and its group companies (collectively, the “Group”) today announced that they have received validation from the Science Based Targets initiative (SBTi)* for the Group’s greenhouse gas (GHG) emissions reduction targets as science-based targets aligned with efforts to limit global warming to 1.5°C.

Science Based Targets (SBTs) are corporate greenhouse gas emissions reduction targets aligned with the Paris Agreement’s goal of limiting global warming to 1.5°C above pre-industrial levels. The targets validated for the Group are shown in the table below.

Category

Target

Near-Term

Scope 1 and 2

Reduce GHG emissions by 63.0% by FY2035 from an FY2024 base year

Scope 2

Increase the annual sourcing of renewable electricity to 100% by FY2030 and maintain through FY2035

Scope 3

Reduce Scope 3 Category 1 and Category 11 emissions by 37.5% by FY2035 from an FY2024 base year

Long-Term

Scope 1 and 2

Reduce GHG emissions by 90.0% by FY2050 from an FY2024 base year

Scope 3

Reduce Scope 3 Category 1 and Category 11 GHG emissions by 90.0% by FY2050 from an FY2024 base year

Net-Zero

Scope 1, 2, and 3

Achieve net-zero GHG emissions across the value chain by FY2050

The Group regards climate change as one of its key management issues and has been working to promote ongoing energy conservation initiatives and expand the use of renewable energy. Since 2023, the Group has maintained net-zero CO2 emissions at its major sites worldwide.
To achieve the newly validated SBTs, the Group will continue to advance energy conservation initiatives and expand the adoption and use of renewable energy, while also expanding low-carbon products and services and strengthening collaboration with suppliers. Through these efforts, the Group will promote reductions in GHG emissions across the entire value chain and contribute to the realization of a sustainable mobility society.

* Science Based Targets initiative (SBTi): Jointly operated by CDP, United Nations Global Compact (UNGC), World Resources Institute (WRI), and World Wide Fund for Nature (WWF), the SBTi encourages companies to set science-based greenhouse gas (GHG) emissions reduction targets to support achievement of the goals of the Paris Agreement.

About Panasonic Automotive Systems Co., Ltd.
Headquartered in Japan, Panasonic Automotive Systems Co., Ltd., (PAS) is a global company with subsidiaries in eight other countries and, as a Tier 1 company, it provides advanced proprietary technologies such as infotainment systems to automakers in Japan and overseas, helping to create comfortable, safe, and secure automobiles. PAS is committed to meeting the expectations of its customers around the world with technologies that stand by people in pursuit of its corporate vision of becoming the “Joy in Motion” design company.
We are changing our company name and brand to Mobitera Inc., effective April 1, 2027. To learn more about our company, please visit https://automotive.panasonic.com/en

View original content to download multimedia:https://www.prnewswire.com/news-releases/panasonic-automotive-systems-group-secures-sbti-validation-for-greenhouse-gas-emissions-reduction-targets-302872654.html

SOURCE Panasonic Corporation of North America

Continue Reading

Trending